Jazz is implementing a robust continuity plan in response to the COVID-19 pandemic in order
to deliver on our purpose: We innovate to transform the lives of patients. Our focus at Jazz is to
life-changing medicines for people with serious diseases — often with limited or no options – so
they can live their
lives more fully, and to support our patient communities in their overall wellness. Especially
during a time of
uncertainty as we live through this global pandemic, Jazz remains dedicated to this purpose.
Jazz is committed to the candidate experience during the COVID-19 outbreak. As a result we have updated our hiring practices to accommodate for a virtual hiring experience. All interactions with the Talent Acquisition team and Hiring Managers will be virtual. We will utilize phone and video interviews during this time. Also, we have adapted our onboarding and new hire process.
Learn more about our response to COVID-19 here.
Jazz has been made aware of fraudulent schemes involving our company name and recruitment. Jazz will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or during telephone, in-person or video interviews. Jazz never requires candidates to send money in exchange for, or as a condition of, an offer of employment with Jazz. Jazz will not require candidates to register for a gmail account or google hangouts and only conducts live in-person interviews. Jazz does not conduct interviews of candidates via google hangouts. All open opportunities at Jazz are posted on the Careers site, https://careers.jazzpharma.com/global/en. Any questions about job listings can be directed to Jazz.Talent@jazzpharma.com.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules and biologics, and through innovative delivery technologies and cannabinoid science. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. Please visit www.jazzpharmaceuticals.com for more information.